Proteinuria-Lowering Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Chronic Kidney Disease Patients: A Real-World Multicentric Study

QR Code

Proteinuria-Lowering Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Chronic Kidney Disease Patients: A Real-World Multicentric Study

Control of dyslipidemia in chronic kidney disease (CKD) is not always guaranteed with statins and/or ezetimibe. Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) have opened up a new era in lipid control, but their effect on renal function and proteinuria in real life have not yet be...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Patricia Muñoz Ramos, Yohana Gil Giraldo, Vicente Álvarez-Chiva, David Arroyo, Cristina Sango Merino, Francesc Moncho Francés, Javier Ocaña, Javier Reque, Emilio Sánchez-Álvarez, José Luis Górriz, Borja Quiroga
Format:	article
Langue:	EN
Publié:	MDPI AG 2021
Sujets:	CKD kidney function PCSK9i proteinuria Microbiology QR1-502
Accès en ligne:	https://doaj.org/article/75a018c902c14923a7af7257c93f444c
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Association of circulating proprotein convertase subtilisin/kexin type 9 concentration, prothrombin time and cardiovascular outcomes: a prospective cohort study
par: Jia Peng, et autres
Publié: (2021)

Proprotein Convertase Subtilisin/Kexin Type 9 and Systemic Inflammatory Biomarker Pentraxin 3 for Risk Stratification Among STEMI Patients Undergoing Primary PCI
par: Zhao X, et autres
Publié: (2021)

Proprotein convertase subtilisin/kexin type 9 (PCSK9) Deficiency is Protective Against Venous Thrombosis in Mice
par: Hui Wang, et autres
Publié: (2017)

Association Between Circulating Proprotein Convertase Subtilisin/Kexin Type 9 Concentrations and Cardiovascular Events in Cardiovascular Disease: A Systemic Review and Meta-Analysis
par: Jiahui Liu, et autres
Publié: (2021)

Proteinuria is independently associated with carotid atherosclerosis: a multicentric study
par: Wencai Jiang, et autres
Publié: (2021)

Estudios en Síndrome de anemia megaloblástica con proteinuria (Imerslund): Intento de una explicación patogénica
par: Bravo,Mireya, et autres
Publié: (1981)

Daño hepatocelular, proteinuria y autoinmunidad: ¿enfermedad multisistémica o coincidencia de enfermedades? Caso clínico
par: Herrera,Patricio, et autres
Publié: (2018)

Inferior vena cava thrombosis as a possible cause of nephrotic-range proteinuria: two case reports
par: Yana Apostolova, et autres
Publié: (2021)

EFFECTIVENESS OF IMMUNOSUPPRESSANTS ALONG WITH ACEI/ARBS IN TREATING PROTEINURIA IN PATIENTS WITH SOLITARY KIDNEY POST NEPHRECTOMY
par: Nadeem Azam, et autres
Publié: (2018)

A spotlight on alirocumab in high cardiovascular risk patients with type 2 diabetes and mixed dyslipidemia: a review on the emerging data
par: Rana K, et autres
Publié: (2019)

Clinical Outcomes of Patients With Primary Membranous Nephropathy and Subnephrotic Proteinuria
par: Peng He, et autres
Publié: (2021)

Proprotein convertase furin inhibits matrix metalloproteinase 13 in a TGFβ-dependent manner and limits osteoarthritis in mice
par: Hilène Lin, et autres
Publié: (2018)

Alto rendimiento clínico entre albuminuria semicuantitativa y proteinuria de 24 horas en pacientes con sospecha de síndrome hipertensivo del embarazo
par: Errázuriz V,Joaquín, et autres
Publié: (2015)

PATTERNS OF CHRONIC KIDNEY DISEASE – MINERAL BONE DISEASE AND ITS RELATIONSHIP WITH SOCIO-DEMOGRAPHIC FACTORS AMONG THE PATIENTS OF CHRONIC KIDNEY DISEASE UNDERGOING HEMODIALYSIS
par: Batool Butt, et autres
Publié: (2021)

Baseline renal functions predict the effect of canakinumab on regression of proteinuria in patients with familial Mediterranean fever
par: Tolga Yildirim, et autres
Publié: (2021)

Effects of immunisation against PCSK9 in mice bearing melanoma
par: Amir Abbas Momtazi-Borojeni, et autres
Publié: (2019)

PCSK9 Gene Polymorphisms Associated With the Risk of Myocardial Infarction in Iranian Patients
par: Farshad Namordizadeh, et autres
Publié: (2021)

Nefropatía C1q en un paciente de 17 años: Caso clínico
par: Panuncio,Ana, et autres
Publié: (2008)

Sanqi Oral Solution Mitigates Proteinuria in Rat Passive Heymann Nephritis and Blocks Podocyte Apoptosis via Nrf2/HO-1 Pathway
par: Xiaowan Wang, et autres
Publié: (2021)

Cardiovascular Safety of Anti-Sclerostin Therapy in Chronic Kidney Disease
par: Daniel Cejka
Publié: (2021)

Pneumonia in Patients with Chronic Kidney Disease Admitted to Nephrology Department of a Tertiary Care Center: A Descriptive Cross-sectional Study
par: Abhishek Pant, et autres
Publié: (2021)

Glomerulonefritis Difusa Aguda Postestreptocócica Estudio Clínico, Histopatológico y Evolutivo
par: Olavarria U,F, et autres
Publié: (1980)

PERFIL CLÍNICO DE EMBARAZADAS CON PREECLAMPSIA Y EMBARAZOS NO COMPLICADOS
par: Chamy P,Verónica, et autres
Publié: (2004)

Safety and Tolerability of PCSK9 Inhibitors: Current Insights
par: Kosmas CE, et autres
Publié: (2020)

Is PCSK9 Associated with Plasma Lipid Levels in a Sub-Saharan African Population of Patients with Obesity and Type 2 Diabetes?
par: Mba CM, et autres
Publié: (2019)

High Unawareness of Chronic Kidney Disease in Germany
par: Susanne Stolpe, et autres
Publié: (2021)

The ensemble learning model is not better than the Asian modified CKD-EPI equation for glomerular filtration rate estimation in Chinese CKD patients in the external validation study
par: Li Zhao, et autres
Publié: (2021)

Plant-Based versus Animal-Based Low Protein Diets in the Management of Chronic Kidney Disease
par: Carmen-Antonia Mocanu, et autres
Publié: (2021)

Nefropatía Diabética
par: Ugarte P.,Francisca, et autres
Publié: (2002)

Enfermedad renal por depósito idiopático de cadenas livianas: Caso clínico
par: Trimarchi,Hernán, et autres
Publié: (2013)

Nefropatías secundarias a paraproteína: perfil clínico a partir de hallazgos histológicos
par: Jerez,Joaquín, et autres
Publié: (2020)

New insights into the pathological development of dyslipidemia in patients with hypothyroidism
par: Xin Su, et autres
Publié: (2021)

Beneficial effects of PCSK9 inhibition with alirocumab in familial hypercholesterolemia involve modulation of new immune players
par: Patrice Marques, et autres
Publié: (2022)

Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol
par: Chandni Bardolia, et autres
Publié: (2021)

Síndrome nefrótico en el niño
par: F,PUGA, et autres
Publié: (1974)

Prevalencia de anemia ferropriva y deficiencia de hierro en una población materno infantil del Área Sur Oriente de Santiago de Chile: 1970
par: WINTER,AUGUSTO, et autres
Publié: (1974)

Assessment of the effect of antiretroviral therapy on renal and liver functions among HIV-infected patients: a retrospective study
par: Wondifraw Baynes H, et autres
Publié: (2016)

Comparative effectiveness of erythropoietin alpha and beta in hemodialysis patients: a single-center prospective observational study
par: Muhammad Nadeem Ahsan, et autres
Publié: (2021)

Inclisiran for the Treatment of Cardiovascular Disease: A Short Review on the Emerging Data and Therapeutic Potential
par: Kosmas CE, et autres
Publié: (2020)

A Phase 1, Randomized, Double-Blind, Single-Dose, Placebo-Controlled Safety, Tolerability, And Pharmacokinetic/Pharmacodynamic Study Of Evolocumab In Healthy Chinese Subjects
par: Liu C, et autres
Publié: (2019)